H.C. Wainwright Reiterates Buy Rating on NovaBridge Biosciences (NBP) following FDA meeting feedback
Go back to H.C. Wainwright Reiterates Buy Rating on NovaBridge Biosciences (NBP) following FDA meeting feedback| (NASDAQ: NBP) | Delayed: 1.96 +0.06 (3.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.90 | 52 Week High | $6.95 | |||
| Open | $1.92 | 52 Week Low | $6.95 | |||
| Day High | $1.97 | P/E | 0.92 | |||
| Day Low | $1.83 | EPS | $2.14 | |||
| Volume | 333,513 | |||||
